FDA Adverse Event Injury Summary report: N

OSS AVL POLY TIB BUSHING SET

MDR report key: 20976754 · Received December 19, 2024

Report

Report Number
0001825034-2024-03020
Event Type
Injury
Date Received
December 19, 2024
Date of Event
August 12, 2021
Report Date
January 21, 2025
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KRO
PMA / PMN Number
K051570
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(4). D10: 161073 - OSS AVL TIBIAL LOCK RING - (B)(6). CP0000901 - AVL RS TIBIAL BEARING SET - (B)(6) G2: FOREIGN COUNTRY: (B)(6). CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION AS IT HAS BEEN DISCARDED. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED.

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. UPON RECEIVING ADDITIONAL INFORMATION OF THE REPORTED EVENT, IT WAS DETERMINED TO BE NOT REPORTABLE AS THIS DEVICE DID NOT DISLOCATE AND WAS FRACTURED DURING EXTRACTION. THE DEVICE INVOLVED IN THE EVENT WILL BE CAPTURED UNDER 0001825034-2024-03022. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT UNDERWENT A KNEE SURGERY. APPROXIMATELY 2 YEARS POST-OP, THE PATIENT WAS REVISED DUE TO A FRACTURED LOCKING RING AND TIBIAL BUSHING, POLY WEAR, AND LUXATION OF THE POLY. ATTEMPTS HAVE BEEN MADE AND ALL AVAILABLE INFORMATION HAS BEEN PROVIDED.

Description of Event or Problem · 0

NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2084096 OSS AVL POLY TIB BUSHING SET PROSTHESIS, KNEE KRO ZIMMER BIOMET, INC. N/A 594260

Patients

Seq Age Sex Outcome Treatment
1 45 YR Male Hospitalization| R SEE H11.